Cizzle Biotechnology Holdings PLC
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings … Read more
Cizzle Biotechnology Holdings PLC (CIZ) - Total Assets
Latest total assets as of June 2025: GBX257.00K GBX
Based on the latest financial reports, Cizzle Biotechnology Holdings PLC (CIZ) holds total assets worth GBX257.00K GBX as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cizzle Biotechnology Holdings PLC - Total Assets Trend (2006–2024)
This chart illustrates how Cizzle Biotechnology Holdings PLC’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cizzle Biotechnology Holdings PLC - Asset Composition Analysis
Current Asset Composition (December 2024)
Cizzle Biotechnology Holdings PLC's total assets of GBX257.00K consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 74.2% |
| Accounts Receivable | GBX103.00K | 20.9% |
| Inventory | GBX2.00K | 0.4% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX0.00 | 0.0% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2006–2024)
This chart illustrates how Cizzle Biotechnology Holdings PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cizzle Biotechnology Holdings PLC's current assets represent 100.0% of total assets in 2024, an increase from 65.8% in 2006.
- Cash Position: Cash and equivalents constituted 74.2% of total assets in 2024, up from 24.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 13.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 20.9% of total assets.
Cizzle Biotechnology Holdings PLC Competitors by Total Assets
Key competitors of Cizzle Biotechnology Holdings PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Cizzle Biotechnology Holdings PLC - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Cizzle Biotechnology Holdings PLC generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Cizzle Biotechnology Holdings PLC is currently not profitable relative to its asset base.
Cizzle Biotechnology Holdings PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.48 | 7.16 | 33.00 |
| Quick Ratio | 0.48 | 7.98 | 33.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX-278.00K | GBX 794.00K | GBX 1.86 Million |
Cizzle Biotechnology Holdings PLC - Advanced Valuation Insights
This section examines the relationship between Cizzle Biotechnology Holdings PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 77.34 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -70.9% |
| Total Assets | GBX492.00K |
| Market Capitalization | $747.56 USD |
Valuation Analysis
Below Book Valuation: The market values Cizzle Biotechnology Holdings PLC's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Cizzle Biotechnology Holdings PLC's assets decreased by 70.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Cizzle Biotechnology Holdings PLC (2006–2024)
The table below shows the annual total assets of Cizzle Biotechnology Holdings PLC from 2006 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | GBX492.00K | -70.94% |
| 2023-12-31 | GBX1.69 Million | -39.21% |
| 2022-12-31 | GBX2.79 Million | +141.13% |
| 2021-12-31 | GBX1.16 Million | +1183.33% |
| 2020-12-31 | GBX90.00K | +446.22% |
| 2019-12-31 | GBX16.48K | -82.84% |
| 2018-12-31 | GBX96.00K | -96.89% |
| 2017-12-31 | GBX3.08 Million | -31.29% |
| 2016-12-31 | GBX4.49 Million | -11.84% |
| 2015-12-31 | GBX5.09 Million | -35.14% |
| 2014-12-31 | GBX7.85 Million | +6.29% |
| 2013-12-31 | GBX7.39 Million | -9.25% |
| 2012-12-31 | GBX8.14 Million | +33.49% |
| 2011-12-31 | GBX6.10 Million | +20.13% |
| 2010-12-31 | GBX5.08 Million | +328.35% |
| 2009-12-31 | GBX1.19 Million | -47.10% |
| 2008-12-31 | GBX2.24 Million | -28.30% |
| 2007-12-31 | GBX3.12 Million | +242.92% |
| 2006-12-31 | GBX911.00K | -- |